Coffee consumption is not related to the metabolic syndrome at the age of 36 years: The Amsterdam Growth and Health Longitudinal Study

European Journal of Clinical Nutrition

Volumn 63, Issue 4, 2009, Pages 536-542

  Driessen, M T ^a   Koppes, L L J ^a   Veldhuis, L ^a,b,c   Samoocha, D ^a   Twisk, J W R ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; COFFEE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; NETHERLANDS; PHYSICAL ACTIVITY; PREVALENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BLOOD PRESSURE; CHOLESTEROL, HDL; COFFEE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; PREVALENCE; REGRESSION ANALYSIS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 64249111578     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2008.6     Document Type: Article

References (45)

1. Agardh EE, Carlsson S, Ahlbom A, Efendic S, Grill V, Hammar N et al (2004). Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 255, 645-652.
2. Ainsworth BE, Haskell WL, Leon AS, Jacobs Jr DR, Montoye HJ, Sallis JF et al. (1993). Compendium of physical activities: Classification of energy costs of human physical activities. Med Sci Sport Exerc 25, 71-80.
3. Arnlov J, Vessby B, Riserus U (2004). Coffee consumption and insulin sensitivity. JAMA 291, 1199-1201.
4. Astrup A, Andersen T, Christensen NJ, Bülow J, Madsen J, Breum L et al. (1990). Impaired glucose-induced thermogenesis and arterial norepinephrine response persist after weight reduction in obese humans. Am J Clin Nutr 51, 331-337.
5. Astrup A, Breum L, Toubro S, Hein P, Quaade F (1992). The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on a energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord 16, 269-277.
6. Bernaards CM, Twisk JW, van Mechelen W, Snel J, Kemper HC (2004). Comparison between self-report and a dipstick method (NicCheck1) to assess nicotine intake. Eur Addict Res 10, 163-167.
7. Bidel S, Hu G, Sundvall J, Karpio J, Tuemilehto J (2006). Effects of coffee consumption on glucose tolerance, serum glucose and insulin levels - a cross-sectional analysis. Horm Metab Res 38, 38-43.
8. Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J (2007). Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr, 1-8 [Epub ahead of print].
9. Bucala R, Vlassara H (1995). Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 26, 875-888.
10. Davidson MB, Schriger DL, Peters AL, Lorber B (1999). Relationship between fasting plasma glucose and glycosylated hemoglobin: Potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281, 1203-1210.
11. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N (2004). Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 110, 2494-2497.
12. Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G (2001). A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Melab Disord 25 652-661.
13. Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD (2005a). The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: The Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 165, 875-882.
14. Ferreira I, Twisk JW, van MW, Kemper HC, Stehouwer CD (2005b). Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: Determinants of the metabolic syndrome in young adults: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 165, 42-48.
15. Ford ES (2005). Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 28, 2745-2749.
16. Ford ES, Giles WH, Dietz WH (2002), Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356-359.
17. Greenberg JA, Axen KV, Schnoll R, Boozer CN (2005). Coffee, tea and diabetes: The role of weight loss and caffeine. Int J Obes (Lond) 29, 1121-1129.
18. Greenberg JA, Boozer CN, Geliebter A (2006). Coffee, diabetes, and weight control. Am J Clin Nutr 84, 682-693.
19. Grundy SM, Brewer Jr HB., Cleeman JI, Smith Jr SC., Lenfant C (2004). Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Artetioscler Thromb Vasc Biol 24 e13-e18.
20. Han TS, van Leer EM, Seidell JC, Lean ME (1995). Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311, 1401-1405.
21. Hino A, Adachi H, Enomoto M, Furuki K, Shigetoh Y, Ohtsuka M et al (2007). Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: An epidemiological study in a general Japanese population. Diabetes Res Clin Pract 76, 383-389.
22. Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J (2006). Joint association of coffee consumption and other factors to the risk of type 2 diabetes: A prospective study In Finland. Int J Obes (Lond) 30, 1742-1749.
23. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683-689.
24. Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ (2001). Coffee consumption and serum lipids: A meta-analysis of randomized controlled clinical trials. Am J Epidemiol 153, 353-362.
25. Jee SH, He J, Whelton PK, Sub I, Klag MJ (1999). The effect of chronic coffee drinking on blood pressure: A meta-analysis of controlled clinical trials. Hypertension 33, 647-652.
26. Koppes LL, Twisk JW, Snel J, van Mechelen W, Kemper HC (2000). Blood cholesterol levels of 32-year-old alcohol consumers are better than of nonconsurners. Pharmacol Biochem Behav 66, 163-167.
27. Lopez-Garcia E, van Dam RM, Ralpathak S, Willett WC, Manson JE, Hu FB (2006a). Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr 83, 674-680.
28. Lopez-Garcia E, van Dam RM, Willet WC, Rimm. EB, Manson JE, Stampfer MJ et al. (2006b). Coffee consumption and coronary heart disease in men and women. A prospective cohort study. Circulation 113, 2045-2053.
29. Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM (2005). Blood pressure response to chronic intake of coffee and caffeine: A meta-analysis of randomized controlled trials. J Hypertens 23, 921-928.
30. Pereira MA, Parker ED, Folsom AR (2006). Coffee consumption and risk of type 2 diabetes mellitus: An 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 166, 1311-1316.
31. Rosengren A, Dotevall A, Willielmsen L, Thelle D, Johansson S (2004). Coffee and incidence of diabetes in Swedish women: A prospective 18-year follow-up study. J Intern Med 255, 89-95.
32. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ et al. (2004). Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140, 1-8.
33. Schaefer B (2004). Coffee consumption and type 2 diabetes mellitus. Ann Intern Med 141, 321-324.
34. Spriet LL, MacLean DA, Dyck DJ, Hultman E, Cederblad G, Graham TE (1992). Caffeine ingestion and muscle metabolism during prolonged exercise in humans. Am J Physiol 262, E891-E898.
35. Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P (2004). Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291, 1213-1219.
36. Twisk JWR (2003). Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. Cambridge University Press: Cambridge, England.
37. van Dam RM, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ (2004). Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type Z diabetes: The Hoorn Study. Diabetologia 47, 2152-2159.
38. van Dam RM, Feskens EJ (2002). Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360, 1477-1478.
39. van Dam RM, Hu FB (2005). Coffee consumption and risk of type 2 diabetes: A systematic review. JAMA 294, 97-104.
40. van Dam RM, Willett WC, Manson JE, Hu FB (2006). Coffee, caffeine, and risk of type 2 diabetes: A prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 29, 398-403.
41. van Soeren MH, Graham TE (1998). Effect of caffeine on metabolism, exercise endurance, and catecholamine responses after withdrawal. J Appl Physiol 85, 1493-1501.
42. Wannamethee SG, Shaper AG, Lennon L, Morris RW (2005). Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165, 2644-2650.
43. Wolffenbuttel BH, Girdano D, Founds HW, Bucala R (1996). Longterm assessment of glucose control by haemoglobin-AGE measurement. Lancet 347, 513-515.
44. Wu T, Willett WC, Hankinson SE, Glovannucci E (2005). Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 28, 1390-1396.
45. Zock PL, Katan MB, Merkus MP, van DM, Harryvan JL (1990). Effect of a lipid-rich fraction from boiled coffee on serum cholesterol. Lancet 335, 1235-1237.